These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 33207810)

  • 1. Emerging Concepts of Hybrid Epithelial-to-Mesenchymal Transition in Cancer Progression.
    Sinha D; Saha P; Samanta A; Bishayee A
    Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33207810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis.
    Garg M
    Expert Rev Mol Med; 2017 Mar; 19():e3. PubMed ID: 28322181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid Epithelial/Mesenchymal State in Cancer Metastasis: Clinical Significance and Regulatory Mechanisms.
    Liao TT; Yang MH
    Cells; 2020 Mar; 9(3):. PubMed ID: 32143517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma.
    Qi XK; Han HQ; Zhang HJ; Xu M; Li L; Chen L; Xiang T; Feng QS; Kang T; Qian CN; Cai MY; Tao Q; Zeng YX; Feng L
    Theranostics; 2018; 8(8):2202-2216. PubMed ID: 29721073
    [No Abstract]   [Full Text] [Related]  

  • 5. Epigenetic regulation of hybrid epithelial-mesenchymal cell states in cancer.
    Sample RA; Nogueira MF; Mitra RD; Puram SV
    Oncogene; 2023 Jul; 42(29):2237-2248. PubMed ID: 37344626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coupling the modules of EMT and stemness: A tunable 'stemness window' model.
    Jolly MK; Jia D; Boareto M; Mani SA; Pienta KJ; Ben-Jacob E; Levine H
    Oncotarget; 2015 Sep; 6(28):25161-74. PubMed ID: 26317796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas.
    Jolly MK; Somarelli JA; Sheth M; Biddle A; Tripathi SC; Armstrong AJ; Hanash SM; Bapat SA; Rangarajan A; Levine H
    Pharmacol Ther; 2019 Feb; 194():161-184. PubMed ID: 30268772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles and epigenetic regulation of epithelial-mesenchymal transition and its transcription factors in cancer initiation and progression.
    Lee JY; Kong G
    Cell Mol Life Sci; 2016 Dec; 73(24):4643-4660. PubMed ID: 27460000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of the hybrid epithelial/mesenchymal phenotype.
    Jolly MK; Tripathi SC; Jia D; Mooney SM; Celiktas M; Hanash SM; Mani SA; Pienta KJ; Ben-Jacob E; Levine H
    Oncotarget; 2016 May; 7(19):27067-84. PubMed ID: 27008704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards elucidating the connection between epithelial-mesenchymal transitions and stemness.
    Jolly MK; Huang B; Lu M; Mani SA; Levine H; Ben-Jacob E
    J R Soc Interface; 2014 Dec; 11(101):20140962. PubMed ID: 25339690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epithelial-mesenchymal transition and cancer stem cells: functional and mechanistic links.
    Liu X; Fan D
    Curr Pharm Des; 2015; 21(10):1279-91. PubMed ID: 25506898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of partial EMT in cancer progression.
    Saitoh M
    J Biochem; 2018 Oct; 164(4):257-264. PubMed ID: 29726955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for partial epithelial-to-mesenchymal transition in enabling stemness in homeostasis and cancer.
    Verstappe J; Berx G
    Semin Cancer Biol; 2023 May; 90():15-28. PubMed ID: 36773819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Computational Systems Biology Approach Identifies SLUG as a Mediator of Partial Epithelial-Mesenchymal Transition (EMT).
    Subbalakshmi AR; Sahoo S; Biswas K; Jolly MK
    Cells Tissues Organs; 2022; 211(6):689-702. PubMed ID: 33567424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NRF2 activates a partial epithelial-mesenchymal transition and is maximally present in a hybrid epithelial/mesenchymal phenotype.
    Bocci F; Tripathi SC; Vilchez Mercedes SA; George JT; Casabar JP; Wong PK; Hanash SM; Levine H; Onuchic JN; Jolly MK
    Integr Biol (Camb); 2019 Jun; 11(6):251-263. PubMed ID: 31329868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.
    Liao TT; Yang MH
    Mol Oncol; 2017 Jul; 11(7):792-804. PubMed ID: 28649800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCAND1 Reverses Epithelial-to-Mesenchymal Transition (EMT) and Suppresses Prostate Cancer Growth and Migration.
    Eguchi T; Csizmadia E; Kawai H; Sheta M; Yoshida K; Prince TL; Wegiel B; Calderwood SK
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NFATc Acts as a Non-Canonical Phenotypic Stability Factor for a Hybrid Epithelial/Mesenchymal Phenotype.
    Subbalakshmi AR; Kundnani D; Biswas K; Ghosh A; Hanash SM; Tripathi SC; Jolly MK
    Front Oncol; 2020; 10():553342. PubMed ID: 33014880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EMT Transition States during Tumor Progression and Metastasis.
    Pastushenko I; Blanpain C
    Trends Cell Biol; 2019 Mar; 29(3):212-226. PubMed ID: 30594349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of epithelial-mesenchymal transition through SUMOylation of transcription factors.
    Bogachek MV; De Andrade JP; Weigel RJ
    Cancer Res; 2015 Jan; 75(1):11-5. PubMed ID: 25524900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.